首页 › 公司 › LPTX
LEAP THERAPEUTICS, INC.（LPTX）高管持股异动
该公司内部人(高管 / 董事 / 10% 以上股东)向 SEC 申报的交易记录。
LEAP THERAPEUTICS, INC.（LPTX）所属行业为医药（SIC 2834）。下方按交易代码、申报人与时间,整理该公司内部人(高管 / 董事 / 10% 以上股东)向 SEC 提交的 Form 4 交易与持股变化记录。
近 12 个月,LEAP THERAPEUTICS, INC.（LPTX）共有 3 笔内部人交易申报,其中公开市场买入 0 笔、卖出 0 笔。具体逐笔记录见下方。
完整申报记录(含历史)
本站从 SEC EDGAR 收录的历史 Form 4 申报(共 128 条,以下为最近 100 条)。此区为完整数据档案,与上方带中文解读的精选申报分开呈现。
| 申报日 | 申报人 | 表单 | 类型 | 金额 | 净股数 |
|---|---|---|---|---|---|
| 2025-07-01 | Jason Baum | 4 | 其他 | — | — |
| 2025-07-01 | John Mark O'mahony | 4 | 其他 | — | — |
| 2025-07-01 | Augustine Lawlor | 4 | 其他 | — | — |
| 2025-04-01 | Douglas E Onsi | 4 | 期权行权取得 | — | 3.3 万股 |
| 2025-04-01 | John Mark O'mahony | 4 | 期权行权取得 | — | 2.3 万股 |
| 2025-04-01 | Jason Baum | 4 | 期权行权取得 | $2,113 | 1.6 万股 |
| 2025-04-01 | Christopher Mirabelli | 4 | 期权行权取得 | $2,135 | 1.6 万股 |
| 2025-04-01 | Cynthia Sirard | 4 | 期权行权取得 | — | 2.3 万股 |
| 2025-04-01 | Christine Granfield | 4 | 期权行权取得 | $2,113 | 1.6 万股 |
| 2025-04-01 | Augustine Lawlor | 4 | 期权行权取得 | $2,495 | 1.5 万股 |
| 2024-11-15 | Douglas E Onsi | 4 | 行权(价内) | $6,024 | 2,136 股 |
| 2024-11-15 | James H Cavanaugh | 4 | 行权(价内) | $601 | 213 股 |
| 2024-11-15 | Augustine Lawlor | 4 | 行权(价内) | $6,024 | 2,136 股 |
| 2024-11-15 | Christopher Mirabelli | 4 | 行权(价内) | $6,024 | 2,136 股 |
| 2024-10-04 | William Li | 4 | 获授予/取得 | — | — |
| 2024-10-04 | Nissim Mashiach | 4 | 获授予/取得 | — | — |
| 2024-10-04 | Patricia A. Martin | 4 | 获授予/取得 | — | — |
| 2024-10-04 | Cynthia Sirard | 4 | 获授予/取得 | — | — |
| 2024-10-04 | Augustine Lawlor | 4 | 获授予/取得 | — | — |
| 2024-10-04 | John Mark O'mahony | 4 | 获授予/取得 | — | — |
| 2024-10-04 | Jason Baum | 4 | 获授予/取得 | — | — |
| 2024-10-04 | Thomas John Dietz | 4 | 获授予/取得 | — | — |
| 2024-10-04 | Christopher Mirabelli | 4 | 获授予/取得 | — | — |
| 2024-10-04 | Christine Granfield | 4 | 获授予/取得 | — | — |
| 2024-10-04 | Christian M Richard | 4 | 获授予/取得 | — | — |
| 2024-10-04 | Joseph Loscalzo | 4 | 获授予/取得 | — | — |
| 2024-10-04 | James H Cavanaugh | 4 | 获授予/取得 | — | — |
| 2024-10-04 | Richard Schilsky | 4 | 获授予/取得 | — | — |
| 2024-10-04 | Douglas E Onsi | 4 | 获授予/取得 | — | — |
| 2024-01-31 | Christine Granfield | 4 | 获授予/取得 | — | — |
| 2024-01-31 | Christian M Richard | 4 | 获授予/取得 | — | — |
| 2024-01-31 | Christopher Mirabelli | 4 | 获授予/取得 | — | — |
| 2024-01-31 | Jason Baum | 4 | 获授予/取得 | — | — |
| 2024-01-31 | Thomas John Dietz | 4 | 获授予/取得 | — | — |
| 2024-01-31 | Patricia A. Martin | 4 | 获授予/取得 | — | — |
| 2024-01-31 | Augustine Lawlor | 4 | 获授予/取得 | — | — |
| 2024-01-31 | Joseph Loscalzo | 4 | 获授予/取得 | — | — |
| 2024-01-31 | Richard Schilsky | 4 | 获授予/取得 | — | — |
| 2024-01-31 | William Li | 4 | 获授予/取得 | — | — |
| 2024-01-31 | John Mark O'mahony | 4 | 获授予/取得 | — | — |
| 2024-01-31 | Douglas E Onsi | 4 | 获授予/取得 | — | — |
| 2024-01-31 | James H Cavanaugh | 4 | 获授予/取得 | — | — |
| 2024-01-31 | Nissim Mashiach | 4 | 获授予/取得 | — | — |
| 2024-01-31 | Cynthia Sirard | 4 | 获授予/取得 | — | — |
| 2024-01-30 | Christopher Mirabelli | 4 | 期权行权取得 | — | 5,000 股 |
| 2024-01-30 | Cynthia Sirard | 4 | 期权行权取得 | — | 5,000 股 |
| 2024-01-30 | Douglas E Onsi | 4 | 期权行权取得 | — | 7,500 股 |
| 2024-01-30 | Augustine Lawlor | 4 | 期权行权取得 | — | 5,000 股 |
| 2024-01-30 | John Mark O'mahony | 4 | 期权行权取得 | — | 5,000 股 |
| 2023-08-25 | William Li | 4 | 获授予/取得 | — | — |
| 2023-08-25 | Joseph Loscalzo | 4 | 获授予/取得 | — | — |
| 2023-08-25 | Christine Granfield | 4 | 获授予/取得 | — | — |
| 2023-08-25 | Christian M Richard | 4 | 获授予/取得 | — | — |
| 2023-08-25 | John Mark O'mahony | 4 | 获授予/取得 | — | — |
| 2023-08-25 | Jason Baum | 4 | 获授予/取得 | — | — |
| 2023-08-25 | Douglas E Onsi | 4 | 获授予/取得 | — | — |
| 2023-08-25 | Richard Schilsky | 4 | 获授予/取得 | — | — |
| 2023-08-25 | Thomas John Dietz | 4 | 获授予/取得 | — | — |
| 2023-08-25 | Christopher Mirabelli | 4 | 获授予/取得 | — | — |
| 2023-08-25 | Patricia A. Martin | 4 | 获授予/取得 | — | — |
| 2023-08-25 | James H Cavanaugh | 4 | 获授予/取得 | — | — |
| 2023-08-25 | Augustine Lawlor | 4 | 获授予/取得 | — | — |
| 2023-08-25 | Nissim Mashiach | 4 | 获授予/取得 | — | — |
| 2023-08-25 | Cynthia Sirard | 4 | 获授予/取得 | — | — |
| 2023-04-04 | William Li | 4 | 获授予/取得 | — | — |
| 2023-04-04 | James H Cavanaugh | 4 | 获授予/取得 | — | — |
| 2023-04-04 | John Mark O'mahony | 4 | 获授予/取得 | — | — |
| 2023-04-04 | Nissim Mashiach | 4 | 获授予/取得 | — | — |
| 2023-04-04 | Thomas John Dietz | 4 | 获授予/取得 | — | — |
| 2023-04-04 | Christopher Mirabelli | 4 | 获授予/取得 | — | — |
| 2023-04-04 | Augustine Lawlor | 4 | 获授予/取得 | — | — |
| 2023-04-04 | Patricia A. Martin | 4 | 获授予/取得 | — | — |
| 2023-04-04 | Christian M Richard | 4 | 获授予/取得 | — | — |
| 2023-04-04 | Douglas E Onsi | 4 | 获授予/取得 | — | — |
| 2023-04-04 | Cynthia Sirard | 4 | 获授予/取得 | — | — |
| 2023-04-04 | Christine Granfield | 4 | 获授予/取得 | — | — |
| 2023-04-04 | Richard Schilsky | 4 | 获授予/取得 | — | — |
| 2023-04-04 | Joseph Loscalzo | 4 | 获授予/取得 | — | — |
| 2023-03-21 | Douglas E Onsi | 4 | 期权行权取得 | — | 66.1 万股 |
| 2022-09-08 | Richard Schilsky | 4 | 获授予/取得 | — | — |
| 2022-09-02 | Douglas E Onsi | 4 | 获授予/取得 | — | — |
| 2022-09-02 | Augustine Lawlor | 4 | 获授予/取得 | — | — |
| 2022-09-02 | Joseph Loscalzo | 4 | 获授予/取得 | — | — |
| 2022-09-02 | Nissim Mashiach | 4 | 获授予/取得 | — | — |
| 2022-09-02 | William Li | 4 | 获授予/取得 | — | — |
| 2022-09-02 | Christopher Mirabelli | 4 | 获授予/取得 | — | — |
| 2022-09-02 | Cynthia Sirard | 4 | 获授予/取得 | — | — |
| 2022-09-02 | John Mark O'mahony | 4 | 获授予/取得 | — | — |
| 2022-09-02 | Thomas John Dietz | 4 | 获授予/取得 | — | — |
| 2022-09-02 | James H Cavanaugh | 4 | 获授予/取得 | — | — |
| 2022-09-02 | Christine Granfield | 4 | 获授予/取得 | — | — |
| 2022-02-03 | James H Cavanaugh | 4 | 获授予/取得 | — | — |
| 2022-02-02 | John Mark O'mahony | 4 | 获授予/取得 | — | — |
| 2022-02-02 | Monica Bertagnolli | 4 | 获授予/取得 | — | — |
| 2022-02-02 | Thomas John Dietz | 4 | 获授予/取得 | — | — |
| 2022-02-02 | Christopher Mirabelli | 4 | 获授予/取得 | — | — |
| 2022-02-02 | William Li | 4 | 获授予/取得 | — | — |
| 2022-02-02 | Nissim Mashiach | 4 | 获授予/取得 | — | — |
| 2022-02-02 | Douglas E Onsi | 4 | 获授予/取得 | — | — |
| 2022-02-02 | Joseph Loscalzo | 4 | 获授予/取得 | — | — |
历史档案为按 SEC 数据集批量收录的申报记录,未逐条生成中文解读;金额 / 净股数由申报字段派生。完整原文以 SEC EDGAR 为准。
常见问题
LEAP THERAPEUTICS, INC.高管最近在买入还是卖出?
近 12 个月,LEAP THERAPEUTICS, INC.（LPTX）的内部人交易申报中,公开市场买入 0 笔、卖出 0 笔。本站只客观呈现申报数据;卖出未必代表看空(见下一问)。
在哪里能查到LEAP THERAPEUTICS, INC.（LPTX）的内部人交易记录?
这些记录来自美国证券交易委员会(SEC)EDGAR 的 Form 3/4/5 公开申报,属公有领域。本页按交易代码(P 公开市场买入 / S 卖出 / M 期权行权等)、申报人与时间,整理了 LPTX 的逐笔内部人交易与交易后持股。 什么是 Form 3 / 4 / 5 →
高管卖出股票代表看空公司吗?
不一定。内部人卖出可能出于行权后缴税、依 10b5-1 预设计划定期减持、个人资产配置或流动性需要等多种原因,与对公司前景的判断未必相关。本站只客观呈现申报数据,不对买卖方向作解读。 什么是 10b5-1 计划 →
LEAP THERAPEUTICS, INC.的内部人交易属于「内幕交易」吗?
Form 3/4/5 是公司内部人依法向 SEC 提交的合法公开披露,与利用未公开重大信息牟利的「内幕交易」(一种违法犯罪)是两回事——二者中文相近,法律含义截然不同。 内部人交易 vs 内幕交易 →